224 related articles for article (PubMed ID: 37881882)
1. Emerging pharmacotherapies for the treatment of pulmonary arterial hypertension.
Auth R; Klinger JR
Expert Opin Investig Drugs; 2023; 32(11):1025-1042. PubMed ID: 37881882
[TBL] [Abstract][Full Text] [Related]
2. Advances in the discovery of drugs that treat pulmonary arterial hypertension.
Zolty R
Expert Opin Drug Discov; 2023 Apr; 18(4):445-466. PubMed ID: 37013267
[TBL] [Abstract][Full Text] [Related]
3. Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension.
Keshavarz A; Kadry H; Alobaida A; Ahsan F
Expert Opin Drug Deliv; 2020 Apr; 17(4):439-461. PubMed ID: 32070157
[No Abstract] [Full Text] [Related]
4. An emerging strategy for targeted therapy of pulmonary arterial hypertension: Vasodilation plus vascular remodeling inhibition.
Hu L; Zhao C; Chen Z; Hu G; Li X; Li Q
Drug Discov Today; 2022 May; 27(5):1457-1463. PubMed ID: 35104622
[TBL] [Abstract][Full Text] [Related]
5. Novel investigational therapies for treating pulmonary arterial hypertension.
Sardana M; Moll M; Farber HW
Expert Opin Investig Drugs; 2015; 24(12):1571-96. PubMed ID: 26484967
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy of refractory pulmonary arterial hypertension.
Ahmed MS; Ghallab M; Ostrow T; Nashawi M; Alagha Z; Levine A; Aronow WS; Lanier GM
Expert Opin Pharmacother; 2023; 24(17):1861-1874. PubMed ID: 37698041
[TBL] [Abstract][Full Text] [Related]
7. Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?
Alamri AK; Ma CL; Ryan JJ
Drugs; 2023 May; 83(7):577-585. PubMed ID: 37017914
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.
Ruopp NF; Cockrill BA
JAMA; 2022 Apr; 327(14):1379-1391. PubMed ID: 35412560
[TBL] [Abstract][Full Text] [Related]
9. Advances in targeted therapy for pulmonary arterial hypertension in children.
Li L; Zhu X; Chen X; Gao J; Ding C; Zhang M; Ma S
Eur J Pediatr; 2023 May; 182(5):2067-2076. PubMed ID: 36527480
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory Mechanisms in the Pathogenesis of Pulmonary Arterial Hypertension: Recent Advances.
Mercurio V; Cuomo A; Naranjo M; Hassoun PM
Compr Physiol; 2021 Apr; 11(2):1805-1829. PubMed ID: 33792903
[TBL] [Abstract][Full Text] [Related]
11. Novel therapeutic approaches for pulmonary arterial hypertension: Unique molecular targets to site-specific drug delivery.
Vaidya B; Gupta V
J Control Release; 2015 Aug; 211():118-33. PubMed ID: 26036906
[TBL] [Abstract][Full Text] [Related]
12. Novel Treatment Pathways in Pulmonary Arterial Hypertension.
Qaiser KN; Tonelli AR
Methodist Debakey Cardiovasc J; 2021; 17(2):106-114. PubMed ID: 34326930
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies.
Waxman AB; Zamanian RT
Am J Cardiol; 2013 Mar; 111(5 Suppl):1A-16A; quiz 17A-19A. PubMed ID: 23414683
[TBL] [Abstract][Full Text] [Related]
14. Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs.
Jin Q; Chen D; Zhang X; Zhang F; Zhong D; Lin D; Guan L; Pan W; Zhou D; Ge J
Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376028
[TBL] [Abstract][Full Text] [Related]
15.
Peng Y; Dai J; Zhao YY
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768713
[TBL] [Abstract][Full Text] [Related]
16. Emerging biologics for the treatment of pulmonary arterial hypertension.
Hye T; Hossain MR; Saha D; Foyez T; Ahsan F
J Drug Target; 2023 Jun; 31(5):1-15. PubMed ID: 37026714
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension.
Zeng C; Liu J; Zheng X; Hu X; He Y
Respir Res; 2023 Nov; 24(1):263. PubMed ID: 37915044
[TBL] [Abstract][Full Text] [Related]
18. Inhalational therapy for pulmonary arterial hypertension: current status and future prospects.
Gupta V; Ahsan F
Crit Rev Ther Drug Carrier Syst; 2010; 27(4):313-70. PubMed ID: 20932241
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil for Pulmonary Arterial Hypertension.
Bhogal S; Khraisha O; Al Madani M; Treece J; Baumrucker SJ; Paul TK
Am J Ther; 2019; 26(4):e520-e526. PubMed ID: 30946047
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
